Could a new paradigm in digital health treat blinding disorders and possibly also be a conduit for treating other parts of the brain? A multi-disciplinary team of world-renowned researchers at USC are exploring this exciting possibility. Building on decades of knowledge, the success of the world’s first FDA-approved retinal implant to restore sight to the blind, and USC’s existing investments, Drs. Mark Humayun, Gianluca Lazzi and Arthur Toga are teaming up to lead a new center (Center for Neuronal Longevity; CNL) to tackle the formidable challenges of neurodegenerative diseases of the eye and brain.
To continue reading this story, click here.